Follow
Cristina Baricordi
Cristina Baricordi
Beam Therapeutics
Verified email at beamtx.com
Title
Cited by
Cited by
Year
Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome
A Aiuti, L Biasco, S Scaramuzza, F Ferrua, MP Cicalese, C Baricordi, ...
Science 341 (6148), 1233151, 2013
12212013
Highly efficient therapeutic gene editing of human hematopoietic stem cells
Y Wu, J Zeng, BP Roscoe, P Liu, Q Yao, CR Lazzarotto, K Clement, ...
Nature medicine 25 (5), 776-783, 2019
4352019
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors
D Pellin, M Loperfido, C Baricordi, SL Wolock, A Montepeloso, ...
Nature communications 10 (1), 2395, 2019
2872019
In vivo tracking of human hematopoiesis reveals patterns of clonal dynamics during early and steady-state reconstitution phases
L Biasco, D Pellin, S Scala, F Dionisio, L Basso-Ricci, L Leonardelli, ...
Cell stem cell 19 (1), 107-119, 2016
2502016
In vivo tracking of T cells in humans unveils decade-long survival and activity of genetically modified T memory stem cells
L Biasco, S Scala, L Basso Ricci, F Dionisio, C Baricordi, A Calabria, ...
Science translational medicine 7 (273), 273ra13-273ra13, 2015
1792015
Retroviral integrations in gene therapy trials
L Biasco, C Baricordi, A Aiuti
Molecular Therapy 20 (4), 709-716, 2012
1492012
Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patients
EB Esrick, JP Manis, H Daley, C Baricordi, H Trébéden-Negre, FJ Pierciey, ...
Blood advances 2 (19), 2505-2512, 2018
792018
Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression
MT Marino, A Grilli, C Baricordi, MC Manara, S Ventura, RS Pinca, ...
Annals of oncology 25 (10), 2080-2086, 2014
462014
Lentivirus-based gene therapy of hematopoietic stem cells in Wiskott-Aldrich syndrome
A Aiuti, L Biasco, S Scaramuzza, F Ferrua, MP Cicalese, C Baricordi, ...
Science (New York, NY) 341 (6148), 1233151, 2013
172013
Circulating miR34a levels as a potential biomarker in the follow-up of Ewing sarcoma
M Sciandra, A De Feo, A Parra, L Landuzzi, PL Lollini, MC Manara, ...
Journal of Cell Communication and Signaling 14, 335-347, 2020
92020
High-throughput analysis of hematopoietic stem cell engraftment after intravenous and intracerebroventricular dosing
RN Plasschaert, MP DeAndrade, F Hull, Q Nguyen, T Peterson, A Yan, ...
Molecular Therapy 30 (10), 3209-3225, 2022
82022
Long-term lymphoid progenitors independently sustain naïve T and NK cell production in humans
N Izotova, C Rivat, C Baricordi, E Blanco, D Pellin, E Watt, AS Gkazi, ...
Nature Communications 12 (1), 1622, 2021
32021
Comprehensive Clonal Mapping of Hematopoiesis in Vivo in Humans By Retroviral Vector Insertional Barcoding
L Biasco, S Scala, F Dionisio, A Calabria, LB Ricci, S Scaramuzza, ...
Blood 124 (21), 5, 2014
32014
Production of genetically engineered T and NK cells is maintained in humans by common long term lymphoid progenitors 15 years after loss of transplanted hematopoietic stem cells
N Izotova, C Rivat, C Baricordi, D Pellin, S Adams, AS Gkazi, E Watt, ...
Molecular Therapy 28 (4), 407-408, 2020
22020
Highly Efficient Therapeutic Gene Editing of BCL11A enhancer in Human Hematopoietic Stem Cells from ss-Hemoglobinopathy Patients for Fetal Hemoglobin Induction
J Zeng, DE Bauer, Y Wu, BP Roscoe, P Liu, Q Yao, C Lazzarrotto, ...
Blood 132, 3482, 2018
22018
Integration site analysis of Wiskott-Aldrich syndrome patients treated with lentiviral vector gene therapy
L Biasco, C Baricordi, F Dionisio, A Calabria, S Scaramuzza, D Pellin, ...
MOLECULAR THERAPY 20, S86-S86, 2012
22012
IS-Seq: a bioinformatics pipeline for integration sites analysis with comprehensive abundance quantification methods
A Yan, C Baricordi, Q Nguyen, L Barbarossa, M Loperfido, L Biasco
BMC Bioinformatics 24 (286), 2023
12023
Genetically engineered microglia-like cells have therapeutic potential for neurodegenerative disease
RN Plasschaert, MP DeAndrade, F Hull, Q Nguyen, T Peterson, A Yan, ...
bioRxiv, 2021.09. 16.460703, 2021
12021
Preclinical lentiviral vector-mediated hematopoietic stem and progenitor cell gene therapy corrects Pompe disease-related muscle and neurological manifestations
JK Yoon, JW Schindler, M Loperfido, C Baricordi, MP DeAndrade, ...
bioRxiv, 2023.11. 03.565442, 2023
2023
Resolving the Heterogeneity and Dynamic Changes of Hematopoietic Stem-Progenitor Cells in Gene Therapy Drug Products
C Baricordi
MOLECULAR THERAPY 30 (4), 343-344, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20